These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 33573706)

  • 1. Potential contributors to low dose methotrexate toxicity in a patient with rheumatoid arthritis and pernicious anemia: case report.
    Jara-Palacios MA; Chun W; Traub NL
    BMC Rheumatol; 2021 Feb; 5(1):5. PubMed ID: 33573706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose methotrexate toxicity leading to pancytopenia: leucovorin as a rescue treatment.
    Schelzel G; Palicherla A; Tauseef A; Millner P
    Proc (Bayl Univ Med Cent); 2024; 37(2):339-343. PubMed ID: 38343452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate-induced Severe Pancytopenia in a Patient with Rheumatoid Arthritis: A Case Report and Review of Literature.
    Hosseini E; Shahbazi F
    Curr Drug Saf; 2024; 19(2):224-235. PubMed ID: 37194235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancytopenia Secondary to Vitamin B12 Deficiency in Older Subjects.
    Costanzo G; Sambugaro G; Mandis G; Vassallo S; Scuteri A
    J Clin Med; 2023 Mar; 12(5):. PubMed ID: 36902847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate Pneumonitis After a Low-Dose Medication Error: A Case Report.
    Silva MM; Ferreira CC; Garcia MA; Pereira E
    Cureus; 2022 Mar; 14(3):e23078. PubMed ID: 35464521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Toxicity of low-dose methotrexate in rheumatoid arthritis--clinical characteristics in patients with MTX-induced pancytopenia and interstitial pneumonitis].
    Ohosone Y; Okano Y; Kameda H; Hama N; Matsumura M; Nojima T; Nakamura K; Kuwana M; Ogasawara T; Hirakata M; Yoshida T; Mimori T; Akizuki M; Ikeda Y
    Ryumachi; 1997 Feb; 37(1):16-23. PubMed ID: 9128419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splenomegaly in a Patient with a History of Pernicious Anemia; the Potential Therapeutic Effects of B12 Therapy.
    Lordi A; Ansari N; Maroules M; Manjegowda A
    Case Rep Hematol; 2022; 2022():2854520. PubMed ID: 35450019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancytopenia after accidental overdose of methotrexate. A complication of low-dose therapy for rheumatoid arthritis.
    Brown MA; Corrigan AB
    Med J Aust; 1991 Oct; 155(7):493-4. PubMed ID: 1921823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancytopenia secondary to hemophagocytic syndrome in rheumatoid arthritis treated with methotrexate and sulfasalazine.
    Sibilia J; Javier RM; Albert A; Cazenave JP; Kuntz JL
    J Rheumatol; 1998 Jun; 25(6):1218-20. PubMed ID: 9632090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychiatric manifestations of vitamin B12 deficiency: a case report].
    Durand C; Mary S; Brazo P; Dollfus S
    Encephale; 2003; 29(6):560-5. PubMed ID: 15029091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Case of Pernicious Anemia Presenting With Severe Hemolysis.
    Romero KN; Patel F; Rai O; Quan A; Reddy P
    Cureus; 2023 Dec; 15(12):e50534. PubMed ID: 38226075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent acute megaloblastic anaemia and pneumonitis: a severe side-effect of low-dose methotrexate therapy during rheumatoid arthritis.
    Bolla G; Disdier P; Harle JR; Verrot D; Weiller PJ
    Clin Rheumatol; 1993 Dec; 12(4):535-7. PubMed ID: 8124920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate-Induced Pancytopenia and Mucositis Caused by Medication Error.
    Amissah-Arthur MB; Baah W
    Ghana Med J; 2020 Mar; 54(1):68-71. PubMed ID: 32863415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients.
    Kivity S; Zafrir Y; Loebstein R; Pauzner R; Mouallem M; Mayan H
    Autoimmun Rev; 2014 Nov; 13(11):1109-13. PubMed ID: 25172240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe pancytopenia associated with low-dose methotrexate therapy for rheumatoid arthritis.
    Calvo-Romero JM
    Ann Pharmacother; 2001 Dec; 35(12):1575-7. PubMed ID: 11793624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Side-effects during treatment of rheumatoid arthritis with methotrexate].
    Bannwarth B; Schaeverbeke T; Labat L; Marce S; Demotes-Mainard F; Dehais J
    Rev Rhum Ed Fr; 1994 May; 61(5):337-42. PubMed ID: 7812288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancytopenia induced by low-dose methotrexate for rheumatoid arthritis.
    Kevat SG; Hill WR; McCarthy PJ; Ahern MJ
    Aust N Z J Med; 1988 Aug; 18(5):697-700. PubMed ID: 3245825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate-associated, early-onset pancytopenia in rheumatoid arthritis.
    Doolittle GC; Simpson KM; Lindsley HB
    Arch Intern Med; 1989 Jun; 149(6):1430-1. PubMed ID: 2730263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate-Induced Mucositis: A Consequence of Medication Error in a Rheumatoid Arthritis Patient.
    Shrestha R; Ojha SK; Jha SK; Jasraj R; Fauzdar A
    Cureus; 2023 Sep; 15(9):e46290. PubMed ID: 37915869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate-induced pancytopenia: a case series of 46 patients.
    Ajmani S; Preet Singh Y; Prasad S; Chowdhury A; Aggarwal A; Lawrence A; Misra R; Mishra R; Agarwal V
    Int J Rheum Dis; 2017 Jul; 20(7):846-851. PubMed ID: 28261918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.